Overview In 2010, an estimated 68,130 new cases of melanoma were diagnosed and approximately 8700 patients died of the disease in the United States. 1 However, these figures for new cases may represent a substantial underestimation, because
Daniel G. Coit, Robert Andtbacka, Christopher J. Anker, Christopher K. Bichakjian, William E. Carson III, Adil Daud, Raza A. Dilawari, Dominick DiMaio, Valerie Guild, Allan C. Halpern, F. Stephen Hodi Jr., Mark C. Kelley, Nikhil I. Khushalani, Ragini R. Kudchadkar, Julie R. Lange, Anne Lind, Mary C. Martini, Anthony J. Olszanski, Scott K. Pruitt, Merrick I. Ross, Susan M. Swetter, Kenneth K. Tanabe, John A. Thompson, Vijay Trisal and Marshall M. Urist
Daniel G. Coit, Robert Andtbacka, Christopher K. Bichakjian, Raza A. Dilawari, Dominick DiMaio, Valerie Guild, Allan C. Halpern, F. Stephen Hodi, Mohammed Kashani-Sabet, Julie R. Lange, Anne Lind, Lainie Martin, Mary C. Martini, Scott K. Pruitt, Merrick I. Ross, Stephen F. Sener, Susan M. Swetter, Kenneth K. Tanabe, John A. Thompson, Vijay Trisal, Marshall M. Urist, Jeffrey Weber and Michael K. Wong
the express written permission of the NCCN © 2009. Disclosures for the NCCN Melanoma Guidelines Panel At the beginning of each NCCN guidelines panel meeting, panel members disclosed any financial support they have received from industry. Through
Richard D. Carvajal, Sharon A. Spencer and William Lydiatt
Mucosal melanoma (MM) is an aggressive and clinically complex malignancy made more challenging by its relative rarity. Of the 68,130 cases of melanoma diagnosed in 2010 in the United States, only 0.8% to 1.8% of these arise from mucosal surfaces
Antoni Ribas
The author was supported in part by K23 CA93376 and the Melanoma Research Foundation during the preparation of this manuscript. References 1. Blattman JN Greenberg PD . Cancer immunotherapy: a treatment for the masses
Daniel G. Coit, John A. Thompson, Alain Algazi, Robert Andtbacka, Christopher K. Bichakjian, William E. Carson III, Gregory A. Daniels, Dominick DiMaio, Marc Ernstoff, Ryan C. Fields, Martin D. Fleming, Rene Gonzalez, Valerie Guild, Allan C. Halpern, F. Stephen Hodi Jr, Richard W. Joseph, Julie R. Lange, Mary C. Martini, Miguel A. Materin, Anthony J. Olszanski, Merrick I. Ross, April K. Salama, Joseph Skitzki, Jeff Sosman, Susan M. Swetter, Kenneth K. Tanabe, Javier F. Torres-Roca, Vijay Trisal, Marshall M. Urist, Nicole McMillian and Anita Engh
2016, an estimated 76,380 patients will be diagnosed with and approximately 10,130 patients will die of melanoma in the United States. 1 However, these figures for new cases may represent a substantial underestimate, as many superficial and in situ
Leslie A. Fecher and Keith T. Flaherty
Clinical Practice Guidelines in Oncology: Melanoma. NCCN Practice Guidelines in Oncology, Version 2, 2008 . Available at: http://www.nccn.org/professionals/physician_gls/PDF/melanoma.pdf . Accessed January 20, 2009 . 4 Balch C Buzaid A Soong S
Michael S. Sabel and Vernon K. Sondak
No benefits or funds were received in support of this study. References 1 Balch CM Buzaid AC Soong S-J . Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma . J Clin Oncol 2001 ; 19
Daniel G. Coit, John A. Thompson, Robert Andtbacka, Christopher J. Anker, Christopher K. Bichakjian, William E. Carson III, Gregory A. Daniels, Adil Daud, Dominick DiMaio, Martin D. Fleming, Rene Gonzalez, Valerie Guild, Allan C. Halpern, F. Stephen Hodi Jr, Mark C. Kelley, Nikhil I. Khushalani, Ragini R. Kudchadkar, Julie R. Lange, Mary C. Martini, Anthony J. Olszanski, Merrick I. Ross, April Salama, Susan M. Swetter, Kenneth K. Tanabe, Vijay Trisal, Marshall M. Urist, Nicole R. McMillian and Maria Ho
: Integrate into professional practice the updates to NCCN Guidelines for Melanoma Describe the rationale behind the decision-making process for developing the NCCN Guidelines for Melanoma NCCN Categories of Evidence and Consensus Category 1: Based
Tejaswi Mudigonda, Daniel J. Pearce, Brad A. Yentzer, Phillip Williford and Steven R. Feldman
N on-melanoma skin cancers (NMSCs), characterized by malignant growth of the epithelial layer or external surface of the skin, are the most prevalent form of skin cancer in the United States. 1 Since the 1960s, the incidence of NMSC has increased
David G. Pfister, Kie-Kian Ang, David M. Brizel, Barbara Burtness, Anthony J. Cmelak, A. Dimitrios Colevas, Frank Dunphy, David W. Eisele, Jill Gilbert, Maura L. Gillison, Robert I. Haddad, Bruce H. Haughey, Wesley L. Hicks Jr., Ying J. Hitchcock, Merrill S. Kies, William M. Lydiatt, Ellie Maghami, Renato Martins, Thomas McCaffrey, Bharat B. Mittal, Harlan A. Pinto, John A. Ridge, Sandeep Samant, Giuseppe Sanguineti, David E. Schuller, Jatin P. Shah, Sharon Spencer, Andrea Trotti III, Randal S. Weber, Gregory Wolf and Frank Worden
Overview Mucosal melanoma (MM) is a rare, very aggressive noncutaneous melanoma that affects the upper aerodigestive tract, genitourinary tract, and anal/rectal region. 1 This portion of the NCCN Clinical Practice Guidelines in Oncology (NCCN
